Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mankind Pharma Limited Call Transcript 2025

Nov 6, 2025

61869_rns_2025-11-06_4eb41594-8aa8-4850-bb26-8d515cb9c7c5.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [559 x 53] intentionally omitted <==

==> picture [559 x 55] intentionally omitted <==

November 6, 2025

BSE Limited

P J Towers, Dalal Street, Mumbai – 400 001

Scrip Code: 543904

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Symbol: MANKIND

Dear Sir/ Madam,

Subject: Investor Conference Call for Q2 & H1 FY26 – Audio Recording

Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2025 under subject ‘Intimation of Investor Conference Call for Q2 & H1 FY26 with Senior Management of Mankind Pharma Limited (“the Company”)’ , the audio recording of the Call held today i.e. November 6, 2025 is available on the website of the Company at: https://www.mankindpharma.com/wpcontent/uploads/2025/11/Q2FY26-Earnings-Call-Audio.mp3.

You are requested to kindly take the same on records.

Thanking You,

Yours Faithfully,

For Mankind Pharma Limited

Digitally signed by HITESH HITESH KUMAR JAIN KUMAR JAIN Date: 2025.11.06 19:48:12 +05'30' Hitesh Kumar Jain Company Secretary & Compliance Officer

==> picture [557 x 60] intentionally omitted <==